Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$22.72 - $31.49 $24.4 Million - $33.9 Million
-1,075,383 Closed
0 $0
Q2 2023

Aug 14, 2023

SELL
$25.3 - $39.67 $16 Million - $25.1 Million
-633,911 Closed
0 $0
Q4 2022

Feb 14, 2023

BUY
$22.28 - $38.71 $23.8 Million - $41.3 Million
1,067,883 New
1,067,883 $32.8 Million
Q3 2022

Nov 13, 2023

BUY
$34.2 - $51.69 $36.8 Million - $55.6 Million
1,075,383 New
1,075,383 $36.8 Million
Q2 2022

Aug 14, 2023

BUY
$23.14 - $49.68 $14.7 Million - $31.5 Million
633,911 New
633,911 $22 Million
Q1 2022

May 12, 2023

SELL
$27.77 - $64.4 $12.1 Million - $27.9 Million
-433,972 Reduced 40.64%
633,911 $27.9 Million
Q1 2022

May 09, 2022

SELL
$27.77 - $64.4 $18.3 Million - $42.4 Million
-658,800 Closed
0 $0
Q4 2021

Mar 09, 2022

BUY
$54.9 - $105.21 $36.2 Million - $69.3 Million
658,800 New
658,800 $41.4 Million
Q3 2021

Nov 14, 2022

BUY
$105.0 - $178.37 $69.2 Million - $118 Million
658,800 New
658,800 $69.4 Million
Q3 2021

Nov 05, 2021

SELL
$105.0 - $178.37 $74.9 Million - $127 Million
-713,009 Closed
0 $0
Q2 2021

Aug 15, 2022

BUY
$125.11 - $180.0 $89.2 Million - $128 Million
713,009 New
713,009 $126 Million
Q2 2021

Aug 10, 2021

SELL
$125.11 - $180.0 $99.7 Million - $143 Million
-796,914 Closed
0 $0
Q1 2021

May 09, 2022

BUY
$126.27 - $191.71 $101 Million - $153 Million
796,914 New
796,914 $106 Million
Q1 2021

May 07, 2021

SELL
$126.27 - $191.71 $105 Million - $160 Million
-833,486 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$81.94 - $135.34 $68.3 Million - $113 Million
833,486 New
833,486 $113 Million
Q4 2020

Feb 10, 2021

SELL
$81.94 - $135.34 $59.8 Million - $98.7 Million
-729,512 Closed
0 $0
Q3 2020

Nov 12, 2021

BUY
$73.3 - $89.48 $53.5 Million - $65.3 Million
729,512 New
729,512 $60.7 Million
Q3 2020

Nov 10, 2020

SELL
$73.3 - $89.48 $55.3 Million - $67.6 Million
-755,054 Closed
0 $0
Q2 2020

Aug 13, 2021

BUY
$48.82 - $82.53 $36.9 Million - $62.3 Million
755,054 New
755,054 $62 Million
Q2 2020

Aug 07, 2020

SELL
$48.82 - $82.53 $38.3 Million - $64.7 Million
-783,788 Closed
0 $0
Q1 2020

May 07, 2021

BUY
$39.1 - $62.9 $30.6 Million - $49.3 Million
783,788 New
783,788 $40.3 Million
Q1 2020

May 08, 2020

SELL
$39.1 - $62.9 $11.3 Million - $18.2 Million
-290,100 Closed
0 $0
Q4 2019

Mar 03, 2020

BUY
$29.79 - $43.06 $8.64 Million - $12.5 Million
290,100 New
290,100 $12.1 Million
Q4 2019

Feb 12, 2020

SELL
$29.79 - $43.06 $8.64 Million - $12.5 Million
-290,100 Closed
0 $0
Q3 2019

Nov 13, 2020

BUY
$30.47 - $37.65 $8.84 Million - $10.9 Million
290,100 New
290,100 $9.39 Million
Q3 2019

Nov 08, 2019

SELL
$30.47 - $37.65 $5.94 Million - $7.34 Million
-194,832 Closed
0 $0
Q2 2019

Aug 13, 2020

BUY
$25.73 - $35.79 $5.01 Million - $6.97 Million
194,832 New
194,832 $6.79 Million
Q2 2019

Aug 09, 2019

SELL
$25.73 - $35.79 $4.76 Million - $6.62 Million
-184,832 Closed
0 $0
Q1 2019

May 11, 2020

BUY
$21.71 - $31.54 $4.01 Million - $5.83 Million
184,832 New
184,832 $5.45 Million

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.84B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.